Back to results
US 6,586,238 B1Granted
Enzymatic nucleic acids containing 5′-and or 3′-cap structures
AssigneeRibozyme Pharmaceuticals, Inc.
InventorsJasenka Matulic-Adamic, Leonid Beigelman, Alexander Karpeisky, Thale Jarvis, Nassim Usman, Anthony DiRenzo, Francine Wincott
Life of this patent
Estimating the term…
Abstract
An enzymatic nucleic acid molecule comprising a 5′- and/or a 3′-cap structure, wherein said structure is not a 5′-5′-linked inverted nucleotide or a 3′-3′-linked inverted nucleotide.
Claims20
A nucleic acid molecule comprising a 5′-cap structure, a 3′-cap structure, or both a 5′- and a 3′-cap structure, wherein said 5′-cap structure is selected from the group consisting of 4′,5′-methylene nucleotide;
- 1-(β-D-erythrofuranosyl) nucleotide;
- 1,3-diamino-2-propyl phosphate, 3-aminopropyl phosphate;
- 12-aminododecyl phosphate;
- hydroxypropyl phosphate;
- 1,5-anhydrohexitol nucleotide;
- L-nucleotide;
- threo-pentofuranosyl nucleotide;
- acyclic 3′,4′-seco nucleotide;
- 3,5-dihydroxypentyl nucleotide;
- and 5′-mercapto moieties, and wherein said 3′-cap structure is selected from the group consisting of 1,5-anhydrohexitol nucleotide;
- L-nucleotide;
- threo-pentofuranosyl nucleotide;
- acyclic 3′,4′-seco nucleotide;
- 3,5-dihydroxypentyl nucleotide;
- 3′-2′-inverted nucleotide moiety;
- 3′-2′-inverted abasic moiety;
- and 1,4-butanediol.
14 more elements
Dependencies are inferred from the claim text.